Paper40604201
Modeling mesenchymal stromal cell support to hematopoiesis within a novel 3D artificial marrow organoid system.
Schell B and 13 others. Sci Rep, 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Modeling mesenchymal stromal cell support to hematopoiesis within a novel 3D artificial marrow organoid system. Papers, record 40604201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40604201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modeling mesenchymal stromal cell support to hematopoiesis within a novel 3D artificial marrow organoid system.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mesenchymal Stem Cells | Major topic |
| Hematopoiesis | Major topic |
| Organoids | Major topic |
| Bone Marrow | Major topic |
| Models, Biological | Major topic |
| Humans | |
| Cell Differentiation | |
| Hematopoietic Stem Cells | |
| Killer Cells, Natural | |
| Bone Marrow Cells |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PRT-K2017-109 | French Ministry of Health and the French National Cancer Institute | PubMed | ||
| PRT-K2017-109 | French Ministry of Health and the French National Cancer Institute | PubMed | ||
| PRT-K2017-109 | French Ministry of Health and the French National Cancer Institute | PubMed | ||
| ALF 2016-07 | Association Laurette Fugain | PubMed |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7529536 | A flow cytometric assay of CD34-positive cell populations in the bone marrow. | Br J Haematol | 1994 | https://conductscience.org/library/papers/7529536 | PubMed |
| 2 | 27373165 | NKp80 Defines a Critical Step during Human Natural Killer Cell Development. | Cell Rep | 2016 | https://conductscience.org/library/papers/27373165 | PubMed |
| 3 | 38221718 | Ex vivo expansion of human hematopoietic stem cells and clinical applications. | Cancer Sci | 2024 | https://conductscience.org/library/papers/38221718 | PubMed |
| 4 | 27777574 | Phenotypic and Functional Dysregulated Blood NK Cells in Colorectal Cancer Patients Can Be Activated by Cetuximab Plus IL-2 or IL-15. | Front Immunol | 2016 | https://conductscience.org/library/papers/27777574 | PubMed |
| 5 | 34760696 | Advancement of Scaffold-Based 3D Cellular Models in Cancer Tissue Engineering: An Update. | Front Oncol | 2021 | https://conductscience.org/library/papers/34760696 | PubMed |
| 6 | 22058205 | Oxygen tension plays a critical role in the hematopoietic microenvironment in vitro. | Haematologica | 2012 | https://conductscience.org/library/papers/22058205 | PubMed |
| 7 | 26140247 | Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer. | Oncoimmunology | 2015 | https://conductscience.org/library/papers/26140247 | PubMed |
| 8 | 17259967 | Transcription factors in myeloid development: balancing differentiation with transformation. | Nat Rev Immunol | 2007 | https://conductscience.org/library/papers/17259967 | PubMed |
| 9 | 22224774 | Neutrophil function: from mechanisms to disease. | Annu Rev Immunol | 2012 | https://conductscience.org/library/papers/22224774 | PubMed |
| 10 | 26414401 | The Aryl Hydrocarbon Receptor Antagonist StemRegenin1 Improves In Vitro Generation of Highly Functional Natural Killer Cells from CD34(+) Hematopoietic Stem and Progenitor Cells. | Stem Cells Dev | 2015 | https://conductscience.org/library/papers/26414401 | PubMed |
| 11 | 35260165 | Hematopoietic differentiation is characterized by a transient peak of entropy at a single-cell level. | BMC Biol | 2022 | https://conductscience.org/library/papers/35260165 | PubMed |
| 12 | 25232355 | Ontogeny of myeloid cells. | Front Immunol | 2014 | https://conductscience.org/library/papers/25232355 | PubMed |
| 13 | 29222239 | Aging, hematopoiesis, and the myelodysplastic syndromes. | Hematology Am Soc Hematol Educ Program | 2017 | https://conductscience.org/library/papers/29222239 | PubMed |
| 14 | 37646021 | Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy. | Front Immunol | 2023 | https://conductscience.org/library/papers/37646021 | PubMed |
| 15 | 31948565 | Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay. | Methods Enzymol | 2020 | https://conductscience.org/library/papers/31948565 | PubMed |
| 16 | 25762174 | Making sense of hematopoietic stem cell niches. | Blood | 2015 | https://conductscience.org/library/papers/25762174 | PubMed |
| 17 | 33072112 | The Neutrophil: Constant Defender and First Responder. | Front Immunol | 2020 | https://conductscience.org/library/papers/33072112 | PubMed |
| 18 | 11014194 | Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. | Nature | 2000 | https://conductscience.org/library/papers/11014194 | PubMed |
| 19 | 28491060 | Shaping of Natural Killer Cell Antitumor Activity by Ex Vivo Cultivation. | Front Immunol | 2017 | https://conductscience.org/library/papers/28491060 | PubMed |
| 20 | 20015543 | The development of a three-dimensional scaffold for ex vivo biomimicry of human acute myeloid leukaemia. | Biomaterials | 2010 | https://conductscience.org/library/papers/20015543 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42314684 | ABO: A 3D stroma-supported culture platform enabling full human B-lymphopoiesis for disease modeling and gene therapy development. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42314684 | PubMed |
| 42196302 | Immunosenescence and Bone Homeostasis: From Mechanisms of Homeostasis Disruption to Therapeutic Opportunities in Age-Related Skeletal Disorders. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42196302 | PubMed |
| 41356260 | Bone marrow mesenchymal stem cells and adipocytes in haematological malignancies. | Oncol Rev | 2025 | https://conductscience.org/library/papers/41356260 | PubMed |
| 40980505 | Liver-bone organoids reveal senescence-driven interorgan crosstalk. | Bioact Mater | 2025 | https://conductscience.org/library/papers/40980505 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40604201
GET https://conductscience.org/api/papers/v1/40604201/references?page=2